JPS6335591A - Globoside neutral glycolipid and production thereof - Google Patents

Globoside neutral glycolipid and production thereof

Info

Publication number
JPS6335591A
JPS6335591A JP17961886A JP17961886A JPS6335591A JP S6335591 A JPS6335591 A JP S6335591A JP 17961886 A JP17961886 A JP 17961886A JP 17961886 A JP17961886 A JP 17961886A JP S6335591 A JPS6335591 A JP S6335591A
Authority
JP
Japan
Prior art keywords
formula
compound
formulas
tables
mathematical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP17961886A
Other languages
Japanese (ja)
Inventor
Tomoya Ogawa
智也 小川
Katsuya Koike
勝也 小池
Masaaki Numata
昌明 沼田
Mamoru Sugimoto
守 杉本
Yoshiaki Nakahara
義昭 中原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIKEN Institute of Physical and Chemical Research
Original Assignee
RIKEN Institute of Physical and Chemical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIKEN Institute of Physical and Chemical Research filed Critical RIKEN Institute of Physical and Chemical Research
Priority to JP17961886A priority Critical patent/JPS6335591A/en
Publication of JPS6335591A publication Critical patent/JPS6335591A/en
Pending legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)

Abstract

NEW MATERIAL:A compound of formula I [R<1> is H, acetyl; R<2> is formula II, formula III (R<3> is H, benzoyl) OH, F]. USE:Diagnostic and therapeutic agent for malignant lymphoma. PREPARATION:For example, a compound of formula I (R<1> is acetyl; R<2> is acetyloxy) is dissolved in a solvent such as dimethylformamide and allowed to react with H2N.NH2.AcOH (Ac is acetyl) at 50 deg.C under stirring. The reaction mixture is diluted with ethyl acetate, rinsed with water and dried over magnesium sulfate. The solution is concentrated under reduced pressure and purified using flash chromatography to give the compound of formula I (R<1> is acetyl; R<2> is OH).

Description

【発明の詳細な説明】 〔産業上の利用分野説明 本発明は新規なグロボ系中性糖脂質およびその糖鎖部分
を構成する3糖化合物ならびにそれらの製造方法に関す
る。
DETAILED DESCRIPTION OF THE INVENTION [Description of Industrial Field of Application] The present invention relates to novel globo-based neutral glycolipids, trisaccharide compounds constituting their sugar chain moieties, and methods for producing them.

〔従来の技術〕 糖脂質Gaf (αl−4)Gaj2 (β1−4)G
j’c(β1−1 ) Cer (Blは、グロボ系ス
フィンゴ糖脂質と呼ばれ、正常な組織や細胞にも微量存
在することが知られている。特に最近該糖脂質はBur
kitt リンパ腫細胞に特に高濃度に存在しているこ
とが発見され(200〜800μg/10mgcell
 residue) 、この細胞に特異的な抗原と考え
られている〔J、ワイルス(Waels)らジャーナル
バイオロジカル ケミストリー(J、B、C,) (1
984)259 14783;サイエンス(Scien
ce)(1983)220 509:l。従ってこの事
実に基いて、糖脂質(B)及びその脂質部分の異性体(
B−cis)の抗体を作成し、これら抗体を悪性リンパ
腫の診断及び、治療に応用することが期待されている。
[Prior art] Glycolipid Gaf (αl-4)Gaj2 (β1-4)G
j'c(β1-1)Cer(Bl) is called a globoglycosphingolipid and is known to exist in trace amounts in normal tissues and cells.In particular, recently this glycolipid has been
kitt was found to be present in particularly high concentrations in lymphoma cells (200-800μg/10mgcell).
residue), is considered to be an antigen specific to this cell [J. Waels et al. Journal of Biological Chemistry (J, B, C,) (1
984) 259 14783;Science
ce) (1983) 220 509:l. Therefore, based on this fact, glycolipids (B) and their lipid moiety isomers (
It is expected that antibodies against B-cis) will be created and these antibodies will be applied to the diagnosis and treatment of malignant lymphoma.

また、糖脂質(B)の位置異性体Gaβ(β1−3)G
aJ2(β1−4)Gjl!c(β1−4 ) Cer
 (Alは、ネズミの乳がん細胞に特徴的に存在し、か
つそこから単離されている。従って該糖脂質図も悪性@
瘍の診断及び治療に応用されることが期待されている(
H,Ar1taetal J、Biochem、(To
kyo) (1974)761067 )。
In addition, positional isomer Gaβ(β1-3)G of glycolipid (B)
aJ2(β1-4)Gjl! c(β1-4) Cer
(Al is characteristically present in murine breast cancer cells and has been isolated from them. Therefore, the glycolipid diagram is also malignant @
It is expected that it will be applied to the diagnosis and treatment of cancer (
H, Ar1taetal J, Biochem, (To
(1974) 761067).

さらに、責孟賢炎発症性大腸菌の人尿管への付着に糖脂
質(Bl及び(B−cis)の糖鎖が受容体となってい
ることが判明しており、これら糖脂質は関連する症例の
診断や治療に有効に利用される可能性が高い(K、ポッ
ク(Back )ら、J、B、C9(1985)260
.8545]。
Furthermore, it has been found that the sugar chains of glycolipids (Bl and (B-cis)) act as receptors for E. coli causing E. coli to adhere to the human ureter, and these glycolipids are responsible for the attachment of E. coli to the human ureter. There is a high possibility that it will be effectively used for diagnosis and treatment (K, Back et al., J, B, C9 (1985) 260
.. 8545].

U (A) 〔発明の目的〕 本発明は上記知見に基き、悪性腫瘍等の抗原としての機
能を発揮するものと期待される新規なりロボ系の糖脂質
およびその糖鎖部分を構成する3糖化合物ならびにその
製造方法を提供することにある。
U (A) [Objective of the Invention] Based on the above findings, the present invention provides novel robot-based glycolipids that are expected to function as antigens for malignant tumors and trisaccharides constituting their sugar chain moieties. The object of the present invention is to provide a compound and a method for producing the same.

〔発明の構成〕[Structure of the invention]

すなわち本発明は、−殺伐CI)によって表わされる糖
脂質化合物に関する。
That is, the present invention relates to a glycolipid compound represented by -Katsu CI).

(式中、R1は水素原子又はアセチル基であり、子又は
ベンゾイル基である)又はフッ素原子であある。) 本発明の化合物の具体例を以下に示す。
(wherein R1 is a hydrogen atom or an acetyl group, and is a benzoyl group) or a fluorine atom. ) Specific examples of the compounds of the present invention are shown below.

以下本発明の化合物の製造法について説明する。The method for producing the compound of the present invention will be explained below.

〔化合物θ力の合成〕[Synthesis of compound θ force]

化合物θ′71の合成経路はスキーム1に示す。 The synthetic route for compound θ'71 is shown in Scheme 1.

まず化合物0力の合成原料となる化合物GDは以下のよ
うに、化合物(1)から化合物(2)、(4)、αQを
経て合成される。
First, compound GD, which is a raw material for the synthesis of compound zero, is synthesized from compound (1) through compounds (2), (4), and αQ as follows.

DB口 化合物(1)はD−ガラクトピラノースをアセチル化す
ることによって容易に人手可能な化合物である。
DB compound (1) is a compound that can be easily prepared by acetylating D-galactopyranose.

化合物(2)は化合物(1〕をチオメチル化することに
よって(尋られる。即ち、例えばチオメチルトリブチン
のようなチオメチル化剤と化合物(1)とを、四塩化ス
ズ等の存在下反応させる。該反応は例えば1.2−ジク
ロロエタン等の溶媒中、−30℃〜100℃の温度で3
0分〜24時間実施することが好ましい。
Compound (2) is obtained by thiomethylating compound (1). That is, a thiomethylating agent such as thiomethyltributin is reacted with compound (1) in the presence of tin tetrachloride or the like. The reaction is carried out in a solvent such as 1,2-dichloroethane at a temperature of -30°C to 100°C.
It is preferable to carry out for 0 minutes to 24 hours.

反応生成物は所望により公知の手段により精製した後に
次の反応に使用することもできる。
The reaction product can be used in the next reaction after being purified by known means if desired.

次いで化合物(4)は化合物(2)をメタノール及びN
aOCH3と反応されることによって得られる。
Then, compound (4) is obtained by converting compound (2) into methanol and N
Obtained by reacting with aOCH3.

該反応は、−50℃〜50℃で30分〜24時間攪拌す
ることにより実施するのが好ましい。反応はほぼ定量的
に進行し、通常反応生成物をそのまま次工程の原料とす
ることができる。
The reaction is preferably carried out by stirring at -50°C to 50°C for 30 minutes to 24 hours. The reaction proceeds almost quantitatively, and the reaction product can usually be used as a raw material for the next step as it is.

化合物σQはまず化合物(4)とNaH及びベンジルブ
ロマイドとを例えばDMF等の溶媒中で反応させること
により得られる。該反応は一50℃〜100℃で30分
〜24時間攪拌することにより実施するのが好ましい。
Compound σQ can be obtained by first reacting compound (4) with NaH and benzyl bromide in a solvent such as DMF. The reaction is preferably carried out by stirring at -50°C to 100°C for 30 minutes to 24 hours.

次いで化合物ODは化合物αQとHg CI!2及びC
aCO3とを例えば80%C83CN水溶液等の溶媒中
反応させることによって得ることができる。該反応は0
℃〜還流温度で30分48時間攪拌下実施するのが好ま
しい。
Compound OD is then compound αQ and Hg CI! 2 and C
It can be obtained by reacting with aCO3 in a solvent such as an 80% C83CN aqueous solution. The reaction is 0
It is preferable to carry out the reaction at a temperature of 30 minutes to 48 hours under stirring at a temperature of 30 minutes to reflux.

化合物口は化合物0υとSOα2とをジクロロメタン、
1.2−ジクロロエタン等の溶媒中、−30〜50℃で
反応させることにより得られる。次いで化合物04)は
化合物02)と化合物03)とをAg5O□CF、、モ
レキュラーシーブ4A。
The compound mouth is the compound 0υ and SOα2 in dichloromethane,
It is obtained by reacting at -30 to 50°C in a solvent such as 1,2-dichloroethane. Next, compound 04) was prepared by combining compound 02) and compound 03) with Ag5O□CF, and molecular sieve 4A.

Agα04 N HgBr2、Hg (CN) 2等の
触媒存在下反応させることによっ゛て得られる。該反応
は1,2−ジクロロエタン、ジクロロメタン、 c、HscHzNOz等の溶媒中−50℃〜100℃で
30分〜24時間攪拌することによって実施することが
好ましい。尚化合物03)は以下のようにして入手する
ことができる。
It can be obtained by reacting in the presence of a catalyst such as Agα04N HgBr2, Hg(CN)2, etc. The reaction is preferably carried out in a solvent such as 1,2-dichloroethane, dichloromethane, c, HscHzNOz, etc. by stirring at -50°C to 100°C for 30 minutes to 24 hours. Compound 03) can be obtained as follows.

化合物09は化合物04)をギ酸、酢酸等の溶媒中、1
0%Pd−C等の触媒存在下、水素気流と接触させるこ
とにより得ることができる。該反応は4℃〜還流温度で
実施することが好ましい。
Compound 09 is obtained by mixing compound 04) in a solvent such as formic acid or acetic acid for 1
It can be obtained by contacting with a hydrogen stream in the presence of a catalyst such as 0% Pd-C. Preferably, the reaction is carried out at a temperature of 4°C to reflux.

化合物(Bは化合物QSIをピリジン等の溶媒中、無水
酢酸と反応させることにより得られる。該反応は一30
℃〜100℃で30分〜24時間攪拌するのが好ましい
Compound (B) can be obtained by reacting compound QSI with acetic anhydride in a solvent such as pyridine.
It is preferable to stir at a temperature of 30 minutes to 24 hours at a temperature of 100°C to 100°C.

化合物Q71はこのようにして得られた化合物αBとH
2N−NH2・AcOHとをDMF等の溶媒中で反応さ
せることにより得られる。該反応は一30℃〜100℃
で1分〜24時間攪拌することにより実施するのが好ま
しい。得られた反応生成物はフラッシニクロマトグラフ
ィー等の公知の精製手段により化合物θ力の純品とする
ことができる。
Compound Q71 is the compound αB and H obtained in this way.
It is obtained by reacting 2N-NH2.AcOH in a solvent such as DMF. The reaction is carried out at -30°C to 100°C.
It is preferable to carry out the reaction by stirring for 1 minute to 24 hours. The obtained reaction product can be made into a pure compound θ by known purification means such as flash chromatography.

〔化合物08)の合成〕 化合物08)、09、(21)、(23)、(24)及
び(25)の合成経路はスキーム2及び3に示す。
[Synthesis of Compound 08)] The synthetic routes of Compounds 08), 09, (21), (23), (24) and (25) are shown in Schemes 2 and 3.

化合物08)は化合物07)とCCl3CN及びNaH
とをAr等の不活性雰囲気下ジクロロメタン等の溶媒中
で反応させることによって得ることができる。
Compound 08) is compound 07) with CCl3CN and NaH
can be obtained by reacting them in a solvent such as dichloromethane under an inert atmosphere such as Ar.

該反応は一30℃〜50℃で10分〜24時間攪拌する
ことによって実施するのが好ましい。
The reaction is preferably carried out by stirring at -30°C to 50°C for 10 minutes to 24 hours.

〔化合物■の合成〕[Synthesis of compound ■]

化合物りは化合物08)とセラミド化合物日とをモレキ
ュラーシーブA W 300、BFJhOlTrOS 
O2CF、、TsOH,5nC1,、Feα3、TrO
3O□CF、とSnα4 、Trα04 とSnα2、
Ag03O2CF3とSnα2 、Ag1JI04  
とSn CJ12 等のセラミド化触媒の存在下反応さ
せることによって得ることができる。該反応はクロロホ
ルム等の溶媒中、−50℃〜100℃、30分24時間
攪拌することによって実施することが好ましい。
The compound 08) and the ceramide compound were mixed with molecular sieve A W 300, BFJhOlTrOS.
O2CF, , TsOH, 5nC1, , Feα3, TrO
3O□CF, and Snα4, Trα04 and Snα2,
Ag03O2CF3 and Snα2, Ag1JI04
It can be obtained by reacting with Sn in the presence of a ceramidation catalyst such as Sn CJ12. The reaction is preferably carried out in a solvent such as chloroform by stirring at -50°C to 100°C for 30 minutes and 24 hours.

化合物■はスキーム3に示すように化合物0ηから化合
物(25)を経由して合成することもできる。
Compound (2) can also be synthesized from compound 0η via compound (25) as shown in Scheme 3.

化合物(25)は化合物0刀とDAST (、ジエチル
アミノサルファトリクルオライド)とをジクロロメタン
等の溶媒中で反応させることによって得られる。
Compound (25) can be obtained by reacting Compound 0 and DAST (diethylaminosulfur trichloride) in a solvent such as dichloromethane.

該反応は一50℃〜100℃で30分〜24時間 ′攪
拌することによって実施するすることが好ましい。次い
で化合物■は化合物(25)とセラミド化合物0!1と
をAgα04、Snα2、モレキュラーシーブ4A等の
前記と同様のセラミド化触媒の存在下反応させることに
よって得られる。該反応はクロロホルム等の溶媒中−5
0℃〜100℃で30分〜24時間攪拌することによっ
て実施するのが好ましい。
The reaction is preferably carried out by stirring at -50°C to 100°C for 30 minutes to 24 hours. Compound (2) can then be obtained by reacting compound (25) with 0:1 of a ceramide compound in the presence of the same ceramidation catalyst as above, such as Agα04, Snα2, and molecular sieve 4A. The reaction is carried out in a solvent such as chloroform.
It is preferably carried out by stirring at 0°C to 100°C for 30 minutes to 24 hours.

このようにして得られた化合物(イ)を含む反応混合物
は適宜フラッシュクロマトグラフィー等の公知手段によ
って精製することができる。
The reaction mixture containing compound (a) thus obtained can be purified as appropriate by known means such as flash chromatography.

〔化合物(21)の合成〕 化合物(21)は化合物(イ)とNaOCH3とを反応
させることにより得られる。該反応はTHF。
[Synthesis of compound (21)] Compound (21) can be obtained by reacting compound (a) with NaOCH3. The reaction is THF.

!Je OH又はそれらの混合物(例えば1:1混合物
)等の溶媒中、−20℃〜100℃で30分〜24時間
攪拌することによって実施することが好ましい。
! It is preferably carried out by stirring in a solvent such as Je OH or a mixture thereof (e.g. 1:1 mixture) at -20<0>C to 100<0>C for 30 minutes to 24 hours.

得られたて化合物(21)を含有する反応混合物をフラ
ッシュクロマトグラフィー等の公知手段を用いて精製す
ることによって化合物(21) CGa1α1−4Ga
nβ1−4 G Ecβ1−1’CerCE(GbOs
e3Cer) )を得ることができる。
Compound (21) CGa1α1-4Ga is obtained by purifying the reaction mixture containing freshly obtained compound (21) using known means such as flash chromatography.
nβ1-4 G Ecβ1-1'CerCE (GbOs
e3Cer) ) can be obtained.

〔化合物り23)の合成〕 化合物(23)は化合物08)とセラミド化合物(22
)とをモレキュラーシーブAW300、BF3Et20
等の前記と同様のセラミド化触媒の存在下反応させるこ
とによって得られる。該反応はクロロホルム等の溶媒中
、−50℃〜100℃で30分〜24時間攪拌下実施す
ることが好ましい。
[Synthesis of compound 23)] Compound (23) is a combination of compound 08) and ceramide compound (22).
) and molecular sieve AW300, BF3Et20
It can be obtained by reacting in the presence of the same ceramidation catalyst as mentioned above. The reaction is preferably carried out in a solvent such as chloroform at -50°C to 100°C with stirring for 30 minutes to 24 hours.

化合物(23)をスキーム3に示すように化合物αつか
ら化合物(25)を経由して合成することもできる。
Compound (23) can also be synthesized from compound α via compound (25) as shown in Scheme 3.

化合物(25)の合成法は前記の通りであり、化合物(
23)は化合物(25)とセラミド化合物(22)とを
前記と同様のセラミド化触媒の存在下反応させることに
よって得られる。該反応はクロロホルム等の溶媒中、−
50℃〜100℃で30分〜24時間攪拌することによ
って実施することが好ましい。
The method for synthesizing compound (25) is as described above, and compound (25) is synthesized as described above.
23) can be obtained by reacting compound (25) and ceramide compound (22) in the presence of the same ceramide catalyst as described above. The reaction is carried out in a solvent such as chloroform, -
It is preferable to carry out the reaction by stirring at 50°C to 100°C for 30 minutes to 24 hours.

〔化合物(24)の合成〕 化合物(24)は化合物(23)とNa0CH1とを反
応させることによって得られる。該反応はTHF、Me
OH又はそれらの混合物(例えば1:1混合物)等の溶
媒中−20℃〜100℃で30分〜24時間攪拌するこ
とによって実施することが好ましい。
[Synthesis of compound (24)] Compound (24) is obtained by reacting compound (23) with Na0CH1. The reaction is performed using THF, Me
It is preferably carried out by stirring in a solvent such as OH or a mixture thereof (for example a 1:1 mixture) at -20°C to 100°C for 30 minutes to 24 hours.

このようにして得られた化合物(24)を含有する反応
混合物をフラッシコクロマトグラフィー等の公知手段を
用いて精製して、化合物(24) CGaβα1−4G
a、&β1−40 Ilcβ1−1 ’ Cer(z)
 )を得ることができる。
The reaction mixture containing compound (24) thus obtained was purified using known means such as flashcochromatography to obtain compound (24) CGaβα1-4G.
a, &β1-40 Ilcβ1-1' Cer(z)
) can be obtained.

以上のようにして1尋られた化合物071.08)、■
、(21)、(23)、(24)及び(25)は新規化
合物である。
Compound 071.08), which was asked as above, ■
, (21), (23), (24) and (25) are new compounds.

〔有用性〕〔Usefulness〕

本発明の化合物は、グロボ系スフィンゴ糖脂質及びその
合成のための中間体であり、該糖脂質の生物機能を解明
するための有用な試薬となりうるちのである。即ち、本
発明の化合物は悪性リンパ腫や悪性腫瘍等の診断及び治
療に応用されることが期待できる。
The compounds of the present invention are globoglycosphingolipids and intermediates for their synthesis, and can serve as useful reagents for elucidating the biological functions of these glycolipids. That is, the compounds of the present invention can be expected to be applied to the diagnosis and treatment of malignant lymphoma, malignant tumors, and the like.

以下本発明を参考例及び実施例により説明する。The present invention will be explained below using reference examples and examples.

尚参考例及び実施例中の反応式中日−はアセチルオキシ
基を示し、□はベンジルオキシ基を示す。
In the reference examples and examples, ``-'' in the reaction formula represents an acetyloxy group, and □ represents a benzyloxy group.

参考例1 化合物(1) 37.7 g (96,58+++mo
le)とチオメチルトリブチン36.9g (109,
45+nmole)を乾燥ジクロロエタン600mlに
溶解し、氷メタノール温度に冷却し、かくはん下凸塩化
スズ17m1(145,71mmole)の乾燥ジクロ
ロエタン溶液200mlを滴加した。滴加後そのままさ
らに3時間攪拌後、飽和フッ化カリ溶液、重曹、氷片の
中に反応液をあけ激しくかくはんした。セライトろ過し
、ろ液は減圧下に濃縮した。残渣はllの酢酸に溶解し
重曹水洗、水洗、飽和食塩水洗し無水硫酸マグネシウム
上に乾燥した。
Reference Example 1 Compound (1) 37.7 g (96,58+++mo
le) and 36.9 g of thiomethyltributin (109,
45+ nmole) was dissolved in 600 ml of dry dichloroethane, cooled to ice methanol temperature, and under stirring a solution of 17 ml (145,71 mmole) of tin chloride in 200 ml of dry dichloroethane was added dropwise. After the dropwise addition, the mixture was stirred for an additional 3 hours, and then the reaction solution was poured into a saturated potassium fluoride solution, sodium bicarbonate, and ice chips, and the mixture was vigorously stirred. It was filtered through Celite, and the filtrate was concentrated under reduced pressure. The residue was dissolved in 1 liter of acetic acid, washed with sodium bicarbonate, water, and saturated saline, and dried over anhydrous magnesium sulfate.

エタノールより再結晶して化合物(2)を2.42g得
た。再結母液はフラッシュクロマト(C−300,80
0g、トルエン=AcO巳t(9:1))で精製し、原
料である化合物を(1)2.219 g、化合物(2)
は再結分と合わせて27.796g(収率80.81%
)化合物(3)0.965g(収率2.81%)で得た
Recrystallization from ethanol yielded 2.42 g of compound (2). The reconsolidation mother liquor was subjected to flash chromatography (C-300,80
0 g, toluene = AcO (9:1)), and the raw material compound (1) was purified to 2.219 g, compound (2)
is 27.796g (yield 80.81%) including recombination.
) Compound (3) 0.965 g (yield 2.81%) was obtained.

尚αとβの比は(1:28.8)であった。Note that the ratio of α and β was (1:28.8).

〔化合物(2)の物性〕 Rf値 0.296()ルエン:Ac0Bt (2: 
1) )mp、113〜113.5℃ エタノール〔α
〕。+1.99°(C=0.94、CH(J 3)元素
分析 計算値 CI sH2□09Sとして:C,47
,61%;H,5,86%;S、8.47%実測値 C
,47,56; H,5,85、S、8.44’tl−
NMR(400MHz、 TMS、 CDα3):  
δ=5.440 (Ill)、 dd。
[Physical properties of compound (2)] Rf value 0.296 () Luene: Ac0Bt (2:
1))mp, 113-113.5℃ Ethanol [α
]. +1.99° (C=0.94, CH (J 3) elemental analysis calculated value CI sH2□09S: C, 47
, 61%; H, 5, 86%; S, 8.47% actual value C
,47,56; H,5,85,S,8.44'tl-
NMR (400MHz, TMS, CDα3):
δ=5.440 (Ill), dd.

C4−H,J=0.25.3.42Hz; 5.269
6(LH)、 t、 C2−H。
C4-H, J=0.25.3.42Hz; 5.269
6(LH), t, C2-H.

J=10.01Hz;  5.0598(ltl)、 
  dd、   C3−H,J=3.42゜10.01
Hz; 4.3966(1)1)、 d、 C1−H,
J=10.01Hz;δ=4.15988.  (1N
)、 dd、 C6−H,J=6.59.11.23;
δ=4.12242.  C(H)、  dd、  J
=6.59. 11.47;3.96466(LH)、
 dt、 C5−H,J=0.25.6.59Hz;2
、2015(3H)、 s、チオメチル基;2.161
8(3H)、 s、アセチル基; 2.1246(3H
)、 S、  アセチル基;2、0843(3N)、 
s、アセチル基;2.0537(3H)、 s、アセチ
ル基;  1.9939(3H)、 s、  アセチル
基”C−NMR(100MHz、 CDα3+ 77、
05ppm) :δ=170.331ppm、 170
.136.169.990.169.600>0: 8
3.385.α、 J=151.4Hz、 78.31
?、 C;?1.835. c; 67.302. C
,66,523,c; 61.405. C6;20、
613.  アセチル;  11.353.チオメチル
参考例2 n■ 化合物(2N、 171 g (3,09mmole)
をメタノール30m1に溶解しこれに0.I N  N
aOCH32mI!を滴加した。室温で一度、攪拌し、
アンバーリスト15で中和し、減圧濃縮すると化合物(
4)が646mg (収率99.43%)で得られた。
J=10.01Hz; 5.0598(ltl),
dd, C3-H, J=3.42゜10.01
Hz; 4.3966(1)1), d, C1-H,
J=10.01Hz; δ=4.15988. (1N
), dd, C6-H, J=6.59.11.23;
δ=4.12242. C(H), dd, J
=6.59. 11.47; 3.96466 (LH),
dt, C5-H, J=0.25.6.59Hz; 2
, 2015(3H), s, thiomethyl group; 2.161
8(3H), s, acetyl group; 2.1246(3H
), S, acetyl group; 2, 0843 (3N),
s, acetyl group; 2.0537 (3H), s, acetyl group; 1.9939 (3H), s, acetyl group"C-NMR (100MHz, CDα3+ 77,
05ppm): δ=170.331ppm, 170
.. 136.169.990.169.600>0:8
3.385. α, J=151.4Hz, 78.31
? , C;? 1.835. c; 67.302. C
, 66, 523, c; 61.405. C6;20,
613. Acetyl; 11.353. Thiomethyl Reference Example 2 n■ Compound (2N, 171 g (3,09 mmole)
was dissolved in 30ml of methanol and added 0.0ml. I N N
aOCH32mI! was added dropwise. Stir once at room temperature,
When neutralized with Amberlyst 15 and concentrated under reduced pressure, the compound (
4) was obtained in an amount of 646 mg (yield 99.43%).

分析用試料はエタノールより再結晶した。Samples for analysis were recrystallized from ethanol.

Rf値 0.350(りooホルム:!JeOH(7:
 3 ) )mp、  132〜133℃(エタノール
)〔α)D−5,08°(C=0.59、CH30H)
元素分析 計算値 C7H140SSとして:C,39
,99%、 H,6,71; S、15.25実測値 
C,39,86; H,6,72j S、 15.22
’H−NMR(400MHz、 T!、lS、 d、−
HeOH):δ=5.21219ppm。
Rf value 0.350 (Rioform:!JeOH(7:
3) ) mp, 132-133°C (ethanol) [α) D-5,08° (C = 0.59, CH30H)
Elemental analysis Calculated value As C7H140SS: C, 39
,99%, H, 6,71; S, 15.25 actual value
C, 39,86; H, 6,72j S, 15.22
'H-NMR (400MHz, T!, lS, d, -
HeOH): δ=5.21219ppm.

d、 C1−H,J=9.52Hz; 3.88151
. dd、  (LH)、 C4−H。
d, C1-H, J=9.52Hz; 3.88151
.. dd, (LH), C4-H.

J=1.23.3.41; 3.57677、 t、 
C2−H,J=9.28;3.52853. ddd、
  (IH)、 C5−H,J=1.23.5.37.
6.6;3.74685. dd、  (1)1)、 
C6−H,J=6.84.11,47;3.67937
. dd、  (1)1)、C6−H’、 J=5.3
7.11.48;4.46380. dd、 C3−H
,J=3.41.9.27; 2.19358. s。
J=1.23.3.41; 3.57677, t,
C2-H, J=9.28; 3.52853. ddd,
(IH), C5-H, J=1.23.5.37.
6.6;3.74685. dd, (1)1),
C6-H, J=6.84.11,47; 3.67937
.. dd, (1)1), C6-H', J=5.3
7.11.48;4.46380. dd, C3-H
, J=3.41.9.27; 2.19358. s.

S−S−C H313C−N  (100MHz、 d6−MeOH
,49,3ppm):δ=87.217pHm (C−
1,J=153.8)1z; 80.004. C5;
75.618. C3; 70.208. C2; 6
9.916. C4; 62.02゜C−6,11,4
81,チオメチル基 参考例3 化合物(4)2.1 g (10mmole)を乾燥D
MFに溶解しこれを、NaH(60%) 3.2 g 
(80mmole)を80m1の乾燥DMFに溶解した
中に、氷メタノール温度にて滴加した。30分間同じ温
度にて攪拌し、ベンジシブC1?イド9.6 m i7
 (80mmole)を同じ温度にて滴加した。室温に
て3時間攪拌し、メタノールを水冷下、発泡しなくなる
まで加え、減圧下に濃縮した。酢酸エチル100mlに
溶解し、水洗、飽和食塩水洗しMg5Os上に乾燥した
減圧濃縮し、フラッシュクロマト(C−300,300
g、ヘキサン: Ac0Et (8: 2) ) テ精
製し、化合物αQを5.22g(収率9 L 46%)
で得た。
S-S-C H313C-N (100MHz, d6-MeOH
,49,3ppm): δ=87.217pHm (C-
1, J=153.8)1z; 80.004. C5;
75.618. C3; 70.208. C2; 6
9.916. C4; 62.02°C-6,11,4
81, Thiomethyl group Reference example 3 2.1 g (10 mmole) of compound (4) was dried D
3.2 g of NaH (60%) dissolved in MF
(80 mmole) was added dropwise into a solution of 80 ml of dry DMF at ice methanol temperature. Stir at the same temperature for 30 minutes, and add Bendisib C1? id 9.6 m i7
(80 mmole) was added dropwise at the same temperature. The mixture was stirred at room temperature for 3 hours, methanol was added under water cooling until foaming ceased, and the mixture was concentrated under reduced pressure. Dissolved in 100 ml of ethyl acetate, washed with water, washed with saturated saline, dried over Mg5Os, concentrated under reduced pressure, and subjected to flash chromatography (C-300, 300).
g, hexane: Ac0Et (8:2)) and purified to give 5.22 g of compound αQ (yield 9 L 46%)
I got it.

Rf値 0.413(ヘキサン:AcOεt (8: 
2))mp、  58〜59℃(ヘキサ7:THF)〔
α)n  +1.59°(C=2.265、CHα3)
元素分析 計算値 C35H380SSとして:’C,
73,66; H,6,71; s、 5.62実測値
 C,73,69; H,6,71; S、5.60’
H−NMR(400MHz、 TMS、CDα3): 
 δ=7.16〜7.40ppm(20)1)、 m、
 Bnの4フェニル: 4.95509(LH)、 d
、 BnのχHz、 J=11.72)1z; 4.8
6227. s、 C5−CH2−φ。
Rf value 0.413 (hexane: AcOεt (8:
2)) mp, 58-59°C (Hex 7: THF) [
α)n +1.59° (C=2.265, CHα3)
Elemental analysis Calculated value As C35H380SS: 'C,
73,66; H, 6,71; s, 5.62 Actual value C, 73,69; H, 6,71; S, 5.60'
H-NMR (400MHz, TMS, CDα3):
δ=7.16-7.40ppm(20)1), m,
Bn 4-phenyl: 4.95509 (LH), d
, χHz of Bn, J=11.72)1z; 4.8
6227. s, C5-CH2-φ.

(1)1) 、 d、 anの×H2,J=10.25
Hz;  4.80975 (1N) 。
(1) 1) , d, an x H2, J = 10.25
Hz; 4.80975 (1N).

d、 Bnの’:X、H2,J=10.26. 4.7
2791 (2H) 、 s、  BnのXH2:  
4.61005 (LH) 、 d、 Bnの::H2
,J=11.72;4、456155(IH)、 d、
  BnのXH2,J=11.72;4.40425(
IH)、 d、 Onの:XH2,J=11.72; 
 4.33616(LH)、 d、 CI−It、 J
=9.52;3.96639(IH)、 d、 C4−
H。
d, Bn': X, H2, J=10.26. 4.7
2791 (2H), s, XH2 of Bn:
4.61005 (LH), d, Bn::H2
, J=11.72; 4, 456155 (IH), d,
Bn XH2, J = 11.72; 4.40425 (
IH), d, On: XH2, J=11.72;
4.33616(LH), d, CI-It, J
=9.52; 3.96639 (IH), d, C4-
H.

J=2.93;  3.84364(18)、 t、 
C2−II、 J=9.52;3.55〜3.62(4
H)、 m、 C3−H,C5−H,C6−H,H’;
2.20518(3H)、 s、 s−CH3I3C−
NMR(100M)12.  [”DCIls、  7
7.001ppm>:δ=138.750. 138.
214. 137.824. 128.369゜128
.125. 127.833. 127.589. 1
27.492. 85.578゜(C1,J=153.
8Hz)、 84.819.77.878.74.41
8゜?3.492. 72.615. 68.618.
 12.669参考例4 σ’1             Qll化合物α17
49mg (1,297mn+ole)、Hg C12
775mg (2,855mmole)、CaCO32
86mg(2,857mmole)を80%C83CN
水溶液にi:iんだくし、還流下、−夜攪拌した。
J=2.93; 3.84364(18), t,
C2-II, J=9.52; 3.55-3.62 (4
H), m, C3-H, C5-H, C6-H, H';
2.20518(3H), s, s-CH3I3C-
NMR (100M)12. [”DCIls, 7
7.001ppm>:δ=138.750. 138.
214. 137.824. 128.369°128
.. 125. 127.833. 127.589. 1
27.492. 85.578° (C1, J=153.
8Hz), 84.819.77.878.74.41
8 degrees? 3.492. 72.615. 68.618.
12.669 Reference Example 4 σ'1 Qll Compound α17
49mg (1,297mn+ole), Hg C12
775mg (2,855mmole), CaCO32
86mg (2,857mmole) of 80% C83CN
The solution was added i:i to an aqueous solution and stirred overnight under reflux.

セライト上にろ過し減圧濃縮後酢酸エチル100m1に
溶解し水洗、飽和食塩水洗し無水硫酸マグネシウム上に
乾燥した。
The mixture was filtered through Celite, concentrated under reduced pressure, dissolved in 100 ml of ethyl acetate, washed with water, washed with saturated saline, and dried over anhydrous magnesium sulfate.

濃縮し、フラッシュクロマト(C−300,90g、ト
ルエン:Ac0Bt (8: 2 ))で精製し化合物
Uυ579mg (収率82.57%)(油状物)で得
た。
It was concentrated and purified by flash chromatography (C-300, 90 g, toluene:Ac0Bt (8:2)) to obtain 579 mg (yield 82.57%) of the compound Uυ (oil).

Rf値 0.134()ルエン:Ac0tEt (9:
 l ) )〔α〕o  +13.12°(C=1.6
35、CHCl、)元素分析 計算値 C34H360
6CH3CO□C2Hsとして、 C,72,59; 
H,7,05実測値 C,72,79; H,6,49
13C−NMR(90MHz、 CDα3.77.04
5):δ=140.059. 139.678. 13
9.193. 130.198゜129.601.12
9.44.129.166、 128.95.128.
79゜127.975.99.099.93.03.8
3.546.82.138゜80.027.78.02
.76.451.76.234.75.909゜74.
717.74.5.74.227.70.708.70
.545.70.328参考例5 化合物QD579mg (L 071mmole)を乾
燥ジクロルエタン4mlに溶解しS 0(J2 1 m
 f! (13,7mmole)及び乾燥DMF数滴を
加え室温で一夜攪拌した。少量のシリカゲルを加えて反
応をとめ減圧下に濃縮した。
Rf value 0.134 () Luene: Ac0tEt (9:
l ) ) [α]o +13.12° (C=1.6
35, CHCl,) Elemental analysis Calculated value C34H360
As 6CH3CO□C2Hs, C,72,59;
H, 7,05 actual measurement value C, 72,79; H, 6,49
13C-NMR (90MHz, CDα3.77.04
5): δ=140.059. 139.678. 13
9.193. 130.198°129.601.12
9.44.129.166, 128.95.128.
79°127.975.99.099.93.03.8
3.546.82.138゜80.027.78.02
.. 76.451.76.234.75.909°74.
717.74.5.74.227.70.708.70
.. 545.70.328 Reference Example 5 579 mg (L 071 mmole) of compound QD was dissolved in 4 ml of dry dichloroethane, and S 0 (J2 1 m
f! (13.7 mmole) and several drops of dry DMF were added and stirred overnight at room temperature. The reaction was stopped by adding a small amount of silica gel and concentrated under reduced pressure.

フラッシュク07ト(C−300,50g、n−ヘキサ
ン:AC○εt(9:1))で精製し、化合物Q21を
558mg (収率93.19%)で(尋だ。
The product was purified by flash-cut 07 (C-300, 50 g, n-hexane: AC○εt (9:1)) to yield 558 mg (yield 93.19%) of compound Q21.

Rf値 0.230(n−ヘキサン+Ac0Et (9
: l) )油状物 〔α)o  +55.56° (C=0.63.  C
Hα3)元素分析 計算値:C3−H3sOsα%Ac
0Etとして二C,73,04%; iL6.31;α
、 6.34実測値 C,72,34、H,6,42’
H−NMR(40MHz、TMS、CDα3.)δH6
,139(d、 1  μ。
Rf value 0.230 (n-hexane + Ac0Et (9
: l)) Oil [α)o +55.56° (C=0.63.C
Hα3) Elemental analysis Calculated value: C3-H3sOsα%Ac
2C as 0Et, 73,04%; iL6.31; α
, 6.34 actual measurement C, 72, 34, H, 6, 42'
H-NMR (40MHz, TMS, CDα3.) δH6
, 139 (d, 1 μ.

J  =3.611z、 H−1) ”C−N!JR(90MHz、  CDα3+  77
.045):  δ= 138.270゜137.72
8. 128.136. 128.027. 127.
867、 127.594゜127.325. 94.
869゜ (C1,J・180.67)1z)、 78.181.
76.178.74.770゜74.444. 73.
196. 73.087. 72.654. 72.2
77゜67.889. 30.449 参考例6 03)                足  ■化合
物(13H,l g (1,131mmole)、化合
物面0.759g (1,358mmole)及びAg
03O2CF30.872 g (3,390mmol
e)を20m1のジクロルエタン20mlに溶解しモレ
キュラーシーブス4A  4g存在下、アルゴン気流中
にて室温で一夜攪拌した。
J = 3.611z, H-1) "C-N!JR (90MHz, CDα3+ 77
.. 045): δ= 138.270°137.72
8. 128.136. 128.027. 127.
867, 127.594°127.325. 94.
869° (C1, J・180.67)1z), 78.181.
76.178.74.770°74.444. 73.
196. 73.087. 72.654. 72.2
77°67.889. 30.449 Reference Example 6 03) Foot ■ Compound (13H, l g (1,131 mmole), compound surface 0.759 g (1,358 mmole) and Ag
03O2CF30.872 g (3,390 mmol
e) was dissolved in 20ml of dichloroethane and stirred overnight at room temperature in an argon stream in the presence of 4g of molecular sieves 4A.

酢酸エチル50m1を加えセライト上に濾過した。減圧
下に濃縮し、フラッシュクロマト(C−300,200
g、n−ヘキサン:AgOεt(8:2>)で精製し、
収率82.51%でα体の化合物04)を924+ng
、β体の化合物a9を284mg得た。α。
50 ml of ethyl acetate was added and the mixture was filtered onto Celite. Concentrate under reduced pressure and perform flash chromatography (C-300, 200
Purified with g,n-hexane:AgOεt (8:2>),
924+ng of α-compound 04) with a yield of 82.51%
, 284 mg of β-compound a9 was obtained. α.

βの比は3.25:1であった。The ratio of β was 3.25:1.

〔化合物04)の物性〕 Rf値 0.423 油状物 〔α〕o  +24.05° (C=0.895. C
HcI23)元素分析 計算値: Cs s H980
+ sとして:C,76、28%;H,6,60% C,76、57%;H,6,61% ”C−NMR(100MHz、 CDCl3.77.0
50):δ= 139.140゜138.799. 1
38.652. 138.457. 138.068.
 137.629゜128.515. 128.223
. 128,125. 127.833. 127.5
89゜127.492. 127.199. 102.
880.  (C1b、J  =157tlz)102
.539 (C1a、    J456.3Hz)、 
 100.784  (C1c、J=164.8)、 
 82.703. 81.728. 79,486. 
76.660. 75゜246、 75.051゜ 74.905. 73.736. 73.199. 7
3.102. 72.468゜72.127. 70.
958. 69.495. 68.326. 67.7
90〔化合物u9の物性〕 Rf値 0.283 油状物 〔α)o  +18.61° (C=1.89.  C
Hα3)元素分析 計算値: Cs s Hs a O
+ sとして:C,76、28%;H,6,60 実測値 C,75,59%;H,6,59I3C−NM
R(1001,lHz、CDα、、 77.045):
  δ= 139.245゜139.137.138.
92.138.704.138.539.138.43
゜137.997.137.62.128.626.1
29.136.128.028゜127.919. 1
27.811. 127.65. 127.542. 
127.325゜127.109. 102.835 
 (C1,J=162.35Hz)、  102.61
9(C1,J=161.14)、  102.51  
(C1,J=161.13)1z)、83.114. 
82.463. 82.03. 81.813..80
.513゜79.971. 76.612. 75.1
47. 74.822. 74.553゜73.849
. 73.361. 73.09. 72.494. 
70.815、?0.11. 69.08. 68.7
56. 68.268参考例7 化合物041906.8mg (0,606mmole
)を酢酸45nlに溶解し、10%PdC,450mg
を加え80℃で2時間、水素添加した。
[Physical properties of compound 04)] Rf value 0.423 Oil [α]o +24.05° (C=0.895.C
HcI23) Elemental analysis Calculated value: Cs s H980
+ As s: C, 76, 28%; H, 6, 60% C, 76, 57%; H, 6, 61% "C-NMR (100 MHz, CDCl 3.77.0
50): δ= 139.140°138.799. 1
38.652. 138.457. 138.068.
137.629°128.515. 128.223
.. 128, 125. 127.833. 127.5
89°127.492. 127.199. 102.
880. (C1b, J = 157tlz) 102
.. 539 (C1a, J456.3Hz),
100.784 (C1c, J=164.8),
82.703. 81.728. 79,486.
76.660. 75°246, 75.051°74.905. 73.736. 73.199. 7
3.102. 72.468°72.127. 70.
958. 69.495. 68.326. 67.7
90 [Physical properties of compound u9] Rf value 0.283 Oil [α) o +18.61° (C=1.89.C
Hα3) Elemental analysis Calculated value: Cs s Hs a O
+ As s: C, 76, 28%; H, 6, 60 Actual value C, 75, 59%; H, 6, 59I3C-NM
R (1001, lHz, CDα, 77.045):
δ= 139.245°139.137.138.
92.138.704.138.539.138.43
゜137.997.137.62.128.626.1
29.136.128.028゜127.919. 1
27.811. 127.65. 127.542.
127.325°127.109. 102.835
(C1, J=162.35Hz), 102.61
9 (C1, J=161.14), 102.51
(C1, J=161.13)1z), 83.114.
82.463. 82.03. 81.813. .. 80
.. 513°79.971. 76.612. 75.1
47. 74.822. 74.553°73.849
.. 73.361. 73.09. 72.494.
70.815,? 0.11. 69.08. 68.7
56. 68.268 Reference Example 7 Compound 041906.8mg (0,606mmole
) in 45 nl of acetic acid, 10% PdC, 450 mg
was added and hydrogenated at 80°C for 2 hours.

セライト上に濾過し、50%エタノールで洗い減圧下に
乾燥し、化合物QSIを305.21T1g (99,
8%)で得た。
Filtered onto Celite, washed with 50% ethanol and dried under reduced pressure, yielding 305.21 T1 g of compound QSI (99,
8%).

Rf(直  0.285   n   BuOH:Et
OH:H2O(2: 2 + 1) 〔α)o  +87.95° (C=0.475. H
2O)’H−NMR(400M)lz、  アセトン、
D20.60℃):δ=5.221495ppm(0,
4H,d、 H−1aα、 J=3.91Hz);4.
96990(LH,d、 H−1c、 J=3.42H
z);  4.65631゜(0,6H,d、 H−1
aβ(3)、J=8.06Hz);  4.5073H
IH,d。
Rf (direct 0.285 n BuOH:Et
OH:H2O(2:2+1) [α)o +87.95° (C=0.475.H
2O)'H-NMR (400M) lz, acetone,
D20.60℃): δ=5.221495ppm (0,
4H, d, H-1aα, J=3.91Hz); 4.
96990 (LH, d, H-1c, J=3.42H
z); 4.65631°(0,6H,d, H-1
aβ(3), J=8.06Hz); 4.5073H
IH, d.

H−1b、 J=7.56Hz) ;4.314(t、
 LM、 J =6.3Hz、 H”5c) ;3、2
84(t、 a6H,J =8.3Hz、 H−2aB
)13C−N!、IR(90!JHz、ジオキサン、6
4.637  D20):δ=103.971. LQ
l、102.96.494.92.541. ?9.6
46゜78.237.76.12275.528.75
.146.74.661,73.035゜72.169
,71.679. 70.923. 69.839. 
69.351゜67.347.61.441.61.1
16.21.130゜化合物αS1316mg (0,
627mmole)を無水ピリジン3mffに溶解し無
水酢酸6.5m1(68,99mmo l e)を加え
室温にて一夜攪拌した。減圧下に濃縮しフラッシュクロ
マト(C−300,50g1トルエン:Ac0Et (
1: 1.5 )で精製し化合物051342mg (
収率6 g、 16%)得た。
H-1b, J=7.56Hz) ;4.314(t,
LM, J = 6.3Hz, H"5c); 3, 2
84 (t, a6H, J = 8.3Hz, H-2aB
)13C-N! , IR (90!JHz, dioxane, 6
4.637 D20): δ=103.971. LQ
l, 102.96.494.92.541. ? 9.6
46°78.237.76.12275.528.75
.. 146.74.661, 73.035°72.169
, 71.679. 70.923. 69.839.
69.351゜67.347.61.441.61.1
16.21.130°Compound αS1316mg (0,
627 mmole) was dissolved in 3 mff of anhydrous pyridine, 6.5 ml (68.99 mmole) of acetic anhydride was added, and the mixture was stirred at room temperature overnight. It was concentrated under reduced pressure and subjected to flash chromatography (C-300, 50g 1 toluene: Ac0Et (
1:1.5) to give compound 051342mg (
Yield: 6 g, 16%).

Rf値 0.471.0.426 ()ルエン:Ac0
Bt (1: 2))(αl o  +62.51° 
(c=0.58.  cHat3)元素分析 計算値:
 C4oHs*o□t ・%C7H8として:C,51
,58%;H,5,77 実測値 C,51,11%;H,5,83’ H−NM
R(400MHz、 CDα、、TMS)δ86.25
2 (d、 0.5tl、 J =3、6Hz;H−1
a α)、 5.690(d、 0.5H,J=8. 
Hz、 −1a8)。
Rf value 0.471.0.426 () Luene: Ac0
Bt (1: 2)) (αl o +62.51°
(c=0.58. cHat3) Elemental analysis Calculated value:
C4oHs*o□t ・As %C7H8: C, 51
,58%; H, 5,77 Actual value C, 51,11%; H, 5,83' H-NM
R (400MHz, CDα, TMS) δ86.25
2 (d, 0.5tl, J = 3, 6Hz; H-1
a α), 5.690 (d, 0.5H, J=8.
Hz, -1a8).

5、591 (bs、 IH,H−4c)I3C−N!
、lR(90Ml(z、 CDα、、 77.045)
:δ= 170.7221)I)m、 170.236
.170.02. 、169.69゜169.153.
 168.554. 128.79. 127,975
. 125.049゜180.884.100.616
.99.315.91.405.88.804゜?6.
72.73.36.72.55.71.肌70,599
.69.624゜69.353.69.082.68.
974.68.649.67.836゜67.07?、
  66.969. 66.752. 61.768.
 61.497゜60.251. 29.096. 2
0.536. 20.319. 20.211実施例1 化合物061326mg (0,3371mmole)
を乾燥DMF1mAに溶解し、82N −NH2・Ac
0840、3mg (0,4383mmole)を加え
50℃で30分攪拌した。酢酸エチル50m1でうすめ
水洗復硫酸マグネシウム上に乾燥した。減圧濃縮しフラ
ッシュクロマト(C−300,50g:トルエン;Ac
0Bt (1: 2 )で精製し化合物Q61を27.
8mg回収し、化合物0ηを242.8mg(収率84
.03%)を得た。
5,591 (bs, IH, H-4c) I3C-N!
, lR(90Ml(z, CDα,, 77.045)
:δ= 170.7221)I)m, 170.236
.. 170.02. , 169.69°169.153.
168.554. 128.79. 127,975
.. 125.049゜180.884.100.616
.. 99.315.91.405.88.804°? 6.
72.73.36.72.55.71. skin 70,599
.. 69.624゜69.353.69.082.68.
974.68.649.67.836°67.07? ,
66.969. 66.752. 61.768.
61.497°60.251. 29.096. 2
0.536. 20.319. 20.211 Example 1 Compound 061326 mg (0,3371 mmole)
was dissolved in 1 mA of dry DMF, and 82N -NH2.Ac
0840, 3 mg (0,4383 mmole) was added and stirred at 50°C for 30 minutes. The mixture was diluted with 50 ml of ethyl acetate, washed with water, and dried over magnesium condensate sulfate. Concentrate under reduced pressure and flash chromatography (C-300, 50g: toluene; Ac
Compound Q61 was purified with 0Bt (1:2) at 27.
8 mg was recovered, and 242.8 mg of compound 0η (yield 84
.. 03%) was obtained.

Rf値 0.184   トルエン:Ac0Bt(1:
2)’H−NMR(400MHz)  δH5,590
(bs、 LH,M−4c)13C−NMR(90MH
z、 CDα、、 77.045)、:  δ= 17
0.397゜170.233. 169.851. 1
69.366、 169.261. 168.715゜
100.7?6. 99.259. 89.832. 
76.720. 76.287゜72.711.71.
896.71.410.69.7g5.69.134゜
68.755.67.943.67.076、61.5
49.60.357゜20.58g、 20.426.
 13.978実施例2 ; ご へ/し ! ? 化合物Q7)237mg (0,2530mmole)
、CCl3CN  101μj2(1,012mmol
e)を乾燥CH2Ce21rr+j2に溶解し、Ar気
流中でNaH(60%) 12.1mg (0,303
6mmole)を加え水冷下、5時間攪拌した。減圧濃
縮し、フラッシュクロマ)(C−300,10g、)ル
エン;Ac0Et (l:2))で精製し、化合物0力
を66.6mg回収し、化合物08)を95.9mg(
収率4 g、 76%)を得た。
Rf value 0.184 Toluene: Ac0Bt (1:
2)'H-NMR (400MHz) δH5,590
(bs, LH, M-4c) 13C-NMR (90MH
z, CDα,, 77.045),: δ= 17
0.397°170.233. 169.851. 1
69.366, 169.261. 168.715°100.7?6. 99.259. 89.832.
76.720. 76.287°72.711.71.
896.71.410.69.7g5.69.134゜68.755.67.943.67.076, 61.5
49.60.357°20.58g, 20.426.
13.978 Example 2; Gohe/Shi! ? Compound Q7) 237mg (0,2530mmole)
, CCl3CN 101μj2 (1,012mmol
e) was dissolved in dry CH2Ce21rr+j2, and NaH (60%) 12.1 mg (0,303
6 mmole) was added thereto, and the mixture was stirred for 5 hours under water cooling. It was concentrated under reduced pressure and purified with flash chroma) (C-300, 10 g, toluene; Ac0Et (l:2)) to recover 66.6 mg of compound 0, and 95.9 mg of compound 08) (
A yield of 4 g, 76%) was obtained.

Rf値 0.420.0.460 )ルエン:Ac0B
t (1: 2 )元素分析 計算値:C41H5□0
□6として;C,45,55%、 H,4,85,N、
1.30゜C9,80 実測値 C,46,73,H,5,16,N、1.33
’)l−NMR(400MHz)  δH,8,648
(S、 LH,C= NH) 、 6.482(d、 
LH,J  =3.8Hz、 fl−1a)、 2.1
32.2.109.2.096゜2、092.2.0?
4.2.066、2.063.2.042.2.011
.1.987(S x 10.30H,Ac X 10
)”C−NMR(90MHz、 CDcis、 77.
045):  δ= 170.397゜170.233
.169.851.169.261.168.664.
160.913゜128.894. 128.084.
 125,210. 100.828. 99.476
゜92.974. 76.772. 75.853. 
72.762. 72.060゜?0.652. 68
.864. 67.997. 67.238. 67.
076゜61.603. 60.357. 20.48
0. 14.086実施例3 リリ    目 乾燥したMS(耐酸性) 100mg存在下に化合物0
8) 50mg (0,0462+nmole)、化合
物(1’l134.9mg (0,0462mmole
)をクロロホ/Llk 1 m l ニ溶解し、訂気流
中氷冷下に6μlのBF3Et20を加え室温で一昼夜
攪拌した。
Rf value 0.420.0.460) Luene: Ac0B
t (1: 2) Elemental analysis Calculated value: C41H5□0
□As 6; C, 45, 55%, H, 4, 85, N,
1.30°C9,80 Actual value C,46,73,H,5,16,N,1.33
') l-NMR (400MHz) δH, 8,648
(S, LH, C=NH), 6.482(d,
LH, J = 3.8Hz, fl-1a), 2.1
32.2.109.2.096°2, 092.2.0?
4.2.066, 2.063.2.042.2.011
.. 1.987 (S x 10.30H, Ac x 10
)"C-NMR (90MHz, CDcis, 77.
045): δ= 170.397°170.233
.. 169.851.169.261.168.664.
160.913°128.894. 128.084.
125,210. 100.828. 99.476
゜92.974. 76.772. 75.853.
72.762. 72.060°? 0.652. 68
.. 864. 67.997. 67.238. 67.
076°61.603. 60.357. 20.48
0. 14.086 Example 3 Compound 0 in the presence of 100 mg of Lili eye-dried MS (acid resistant)
8) 50mg (0,0462+nmole), compound (1'l134.9mg (0,0462mmole)
) was dissolved in 1 ml of chlorophore/Llk, 6 μl of BF3Et20 was added under ice-cooling in a stream of air, and the mixture was stirred at room temperature overnight.

セライト上にろ過し減圧濃縮後、フラッシュクロマト(
C−300、トルエン;Ac0Et (1: 2 ’)
又は(1: 1) )で精製し化合物(イ)、10mg
(収率13.03%)を得た。
After filtering on Celite and concentrating under reduced pressure, flash chromatography (
C-300, toluene; Ac0Et (1:2')
or (1:1)) and purified compound (a), 10 mg
(yield: 13.03%).

Rf値  0.62)ルエン:Ac0Et (1: 2
 )e 〔α〕 ロ   +35.47 °  (C=0.5.
CHC3)元素分析 計算値: C5qHrx702a
Nとして;C,62,91%、 ’H,8,31; N
、 0.84゜実測値 C,62,77; H,8,3
0; N、0.84゜’ H−NMR(400MHzC
Dα3. TMS)δH,5,867(dt、IH,J
=6.9と15.4Hz、 H−5セラミド)。
Rf value 0.62) Luene: Ac0Et (1: 2
) e [α] b +35.47 ° (C=0.5.
CHC3) Elemental analysis Calculated value: C5qHrx702a
As N; C, 62,91%, 'H, 8,31; N
, 0.84°Actual measurement C, 62,77; H, 8,3
0; N, 0.84°' H-NMR (400MHzC
Dα3. TMS) δH, 5,867 (dt, IH, J
= 6.9 and 15.4 Hz, H-5 ceramide).

5、751(d、 IH,J=9.0Hz、 NH)。5, 751 (d, IH, J=9.0Hz, NH).

5、581 (d、 IH,J = 2.4Hz、 H
−4c)5、540 (t、 IH,J = 7−3)
1z、 H−3セラミド)5.471(dd、IH,J
 =7.8 と15. IHz、 H−4セラミド) 5.384(dd、ill、J =3−2と11.0.
 Hz、 H−3c)。
5,581 (d, IH, J = 2.4Hz, H
-4c) 5,540 (t, IH, J = 7-3)
1z, H-3 ceramide) 5.471 (dd, IH, J
=7.8 and 15. IHz, H-4 Ceramide) 5.384 (dd, ill, J = 3-2 and 11.0.
Hz, H-3c).

4、979 (d、 IH,J = 3−7Hz、 f
l−1c) 。
4,979 (d, IH, J = 3-7Hz, f
l-1c).

4、480(d、 IH,J=8.1t(z、 H−1
b)。
4,480(d, IH, J=8.1t(z, H-1
b).

4、461 (d、 LH,J =7.8Hz、 H−
1a)実施例4 2IIm      四  〇 化合物□ l Omg (0,00602mmole)
を乾燥THF :MeOH(1: 1)の混液1mjl
’に溶解し、5%NaOCH310p R(0,021
4mmole)加え室温で5時間攪拌した。
4,461 (d, LH, J = 7.8Hz, H-
1a) Example 4 2IIm 4 〇Compound□l Omg (0,00602mmole)
Dry 1 mjl of a mixture of THF:MeOH (1:1)
' and 5% NaOCH310pR (0,021
4 mmole) and stirred at room temperature for 5 hours.

アンバーリスト15で中和後、減圧濃縮しセファデック
ス2H20(lX30cm、クロロホルム:MeOH:
 H2O(60: 30 :4.6) )で精製し化合
物(21)を5.7mg(83,30%)で得た。
After neutralizing with Amberlyst 15, it was concentrated under reduced pressure and Sephadex 2H20 (lx30cm, chloroform:MeOH:
Purification with H2O (60:30:4.6) gave 5.7 mg (83,30%) of compound (21).

Rf値  0.398  りooホルム:MeOH: 
H2O(60: 30 :4.6) 〔α)o  +19.04° (C=0.355.ピリ
ジン)寡)1−NMR(400MHz、 49 ニーI
DMSodg −ロ、OTMS) :5.564(d、
IH,J =6.8と15.4Hz、 H−5セラミド
) 5、385 (dd、 1N、 J =6.6と15−
2Hz、 H−4セラミド)。
Rf value 0.398 Riooform:MeOH:
H2O (60: 30: 4.6) [α)o +19.04° (C=0.355.pyridine) 1-NMR (400MHz, 49 Knee I
DMSodg-ro, OTMS): 5.564 (d,
IH, J = 6.8 and 15.4 Hz, H-5 ceramide) 5,385 (dd, 1N, J = 6.6 and 15-
2Hz, H-4 ceramide).

4、825(d、 LH,J  =3.9)1z、 H
−1c)。
4,825 (d, LH, J = 3.9) 1z, H
-1c).

4.284(d、1)I、J  =7.3)1z、)l
−1b)。
4.284(d,1)I,J =7.3)1z,)l
-1b).

4、179 (d、 LH,J  =7.8Hz、 H
−1a)。
4,179 (d, LH, J = 7.8Hz, H
-1a).

4、068(t、 LH,J  =6.8Hz、 H−
5c)。
4,068(t, LH, J =6.8Hz, H-
5c).

3、’944(dd、 IH,J=5.4と10.3H
z、 H−1セラミド)。
3, '944 (dd, IH, J=5.4 and 10.3H
z, H-1 ceramide).

3、925(t、 IH,J  =7.3Hz、 H−
3セラミ ド)。
3,925 (t, IH, J = 7.3Hz, H-
3 ceramide).

3、826 (d、 LH,J  = 3. (lHz
、 H−4c) 。
3,826 (d, LH, J = 3. (lHz
, H-4c).

3、776(d、 1)1. J  =3.0Hz、 
H−4b)。
3,776(d, 1)1. J = 3.0Hz,
H-4b).

3、063(t、 1)1. J =8.1)1z、 
)I−2a)実施例5 化合物18134.9mg (0,03228mmol
e)、化合物22.24mg (0,03179mmo
le)をMS、 AW100mg存在下、クロロホルム
0.71に溶解し、水冷下ホロンートリフルオロニーテ
レ−トロμβ(0,04878mmole)を滴加し室
温で一夜攪拌した。フラッシュクロマト(C−300,
6g1 トルエン;酢エチル(1:1))で精製し化合
物(23)17.8mg(収率33.71%)を得た。
3,063(t, 1)1. J = 8.1) 1z,
)I-2a) Example 5 Compound 18134.9mg (0,03228mmol
e), compound 22.24 mg (0,03179 mmo
In the presence of 100 mg of MS and AW, 100 mg of MS and AW were dissolved in 0.71 g of chloroform, and phoron-trifluoronite terretro μβ (0,04878 mmole) was added dropwise under water cooling, followed by stirring overnight at room temperature. Flash chromatography (C-300,
The product was purified with 6 g of toluene and ethyl acetate (1:1) to obtain 17.8 mg of compound (23) (yield: 33.71%).

Rf値 0.632)ルエン:酢エチル(1:2)〔α
)o  +39.70° (C=0.845. CHα
、)元素分析 計算値: CayH+3tNO2s・H
2Oとして;C,62,24%、 !(,8,34,N
、0.83実測値 C,62,13、)1,8.19.
 N、0.97実施例6 U 化合物(23)、47mg (0,02830mmol
e)燥したTHF :!、1eOH(1: 1 )の混
液2m溶解し、5%Na0CH,347pi! (0,
1mmol水冷下加え、室温で2時間攪拌した。アンバ
スト15で中和し、セファデックス2H−2(IX30
cm、クロロホルム:MeOH:H2((60:30:
4.6)でゲル濾過し化合物(228,6mg(収率8
8.93%)で得た。
Rf value 0.632) Luene:ethyl acetate (1:2) [α
)o +39.70° (C=0.845.CHα
,) Elemental analysis Calculated value: CayH+3tNO2s・H
As 2O; C, 62, 24%, ! (,8,34,N
, 0.83 actual value C, 62, 13, ) 1, 8.19.
N, 0.97 Example 6 U Compound (23), 47 mg (0,02830 mmol
e) Dried THF:! , 1eOH (1:1) dissolved in 2m of a mixed solution, 5% Na0CH, 347pi! (0,
1 mmol was added under water cooling, and the mixture was stirred at room temperature for 2 hours. Neutralize with Ambust 15, Sephadex 2H-2 (IX30
cm, chloroform:MeOH:H2((60:30:
4.6) to obtain the compound (228.6 mg (yield: 8
8.93%).

Rf(m  O,528クロロホルム;メタノールH2
0(60: 30 :4.6) (:αl o  +18.02° (C= 1.355
.ピリジン)実施例7 化合物0η49.1mg (0,0524mmole)
を乾燥CH2G21m1)に添加し氷冷下DAST12
.3μβ(0,1048mmole)を加え室温で一夜
、攪拌した。CH2C12で希釈し水洗後、フラッシュ
クロマト(C−300,7g、ヘキサン:THF(1:
1))で精製し化合物(25)、25.8mg(94,
3%)で得た。
Rf (m O, 528 chloroform; methanol H2
0 (60: 30: 4.6) (:αl o +18.02° (C= 1.355
.. Pyridine) Example 7 Compound 0η49.1mg (0,0524mmole)
was added to 21 ml of dry CH2G and DAST12 was added under ice cooling.
.. 3 μβ (0,1048 mmole) was added and stirred at room temperature overnight. After diluting with CH2C12 and washing with water, flash chromatography (C-300, 7g, hexane:THF (1:
1)) to give compound (25), 25.8 mg (94,
3%).

Rr値  0.410  ヘキサン:THF (1: 
1)IH−NMR(400MHz、 COα3)TMS
)δH5,740(d、 0.09H。
Rr value 0.410 Hexane:THF (1:
1) IH-NMR (400MHz, COα3) TMS
) δH5,740 (d, 0.09H.

J3.3Hz、 dd、 H−1a α) 、 5.5
86 (d、 LH,J = 2.4Hz、 H−4c
) 。
J3.3Hz, dd, H-1a α), 5.5
86 (d, LH, J = 2.4Hz, H-4c
).

5、411 (dd、 LH,J =5.1.53.0
Hz、 H−1a β)、 2.136 (S。
5,411 (dd, LH, J =5.1.53.0
Hz, H-1a β), 2.136 (S.

6H)、 2.132(3,3)1)、 2.113(
s、 3H)、 2.085(S、 3H)。
6H), 2.132(3,3)1), 2.113(
s, 3H), 2.085 (S, 3H).

2、079 (S、 3H)、 2.075 (S、 
3H)、 2.055 (3,6H) 、 1.994
(S、 3H) 、 ACx 10 実施例8 Ag(JO48,6mg (0,0415mmole)
、5nce28.2mg (0,04342mmole
)、MS4A   300mgを乾燥しておきそれに化
合物(19)21mg(0,02265mmole)及
び化合物(25)14.2mg(0,01888+r+
+nole)をCHα31mlに溶解したちの水冷下加
えた。室温で一夜攪拌し、CHα3で希釈し飽和重曹水
洗しフラッシュクロマト(C−300,5g、へキサン
:THF(6:4))で精製し、化合物(イ)9.2m
g(29,3%)で得た。
2,079 (S, 3H), 2.075 (S,
3H), 2.055 (3,6H), 1.994
(S, 3H), ACx 10 Example 8 Ag (JO48,6mg (0,0415mmole)
, 5nce28.2mg (0,04342mmole
), 300 mg of MS4A was dried, and 21 mg (0,02265 mmole) of compound (19) and 14.2 mg (0,01888+r+) of compound (25) were added to it.
+nole) was dissolved in 31 ml of CHα and added under water cooling. Stir overnight at room temperature, dilute with CHα3, wash with saturated sodium bicarbonate water, and purify with flash chromatography (C-300, 5 g, hexane:THF (6:4)) to obtain 9.2 m of compound (a).
g (29.3%).

Claims (14)

【特許請求の範囲】[Claims] (1)一般式〔 I 〕によって表わされる化合物。 ▲数式、化学式、表等があります▼〔 I 〕 (式中、R^1は水素原子又はアセチル基であり、R^
2は水酸基、▲数式、化学式、表等があります▼、▲数
式、化学式、表等があります▼、 ▲数式、化学式、表等があります▼ (式中、R^3は水素原子又はベンゾイル基である)又
はフッ素である。)
(1) A compound represented by the general formula [I]. ▲There are mathematical formulas, chemical formulas, tables, etc.▼[I] (In the formula, R^1 is a hydrogen atom or an acetyl group, and R^
2 is a hydroxyl group, ▲There are mathematical formulas, chemical formulas, tables, etc.▼, ▲There are mathematical formulas, chemical formulas, tables, etc.▼, ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (In the formula, R^3 is a hydrogen atom or a benzoyl group ) or fluorine. )
(2)一般式〔 I 〕で表わされる化合物(16)(式
中、R^1はアセチル基であり、R^2はアセチルオキ
シ基である。)とH_2N・NH_2・AcOHとを反
応させることからなる一般式〔 I 〕で表わされる化合
物(17)(式中、R^1はアセチル基であり、R^2
は水酸基である。)の製造方法。 ▲数式、化学式、表等があります▼〔 I 〕
(2) Reacting the compound (16) represented by the general formula [I] (in the formula, R^1 is an acetyl group and R^2 is an acetyloxy group) and H_2N・NH_2・AcOH Compound (17) represented by the general formula [I] consisting of (wherein R^1 is an acetyl group, R^2
is a hydroxyl group. ) manufacturing method. ▲There are mathematical formulas, chemical formulas, tables, etc.▼〔I〕
(3)反応をDMF中で実施する特許請求の範囲第(2
)項記載の製造方法。
(3) Claim No. 2 in which the reaction is carried out in DMF
) The manufacturing method described in section 2.
(4)一般式〔 I 〕で表わされる化合物(17)(式
中、R^1はアセチル基であり、R^2は水酸基である
)とCCl_3CN及びNaHとを反応させることから
なる一般式〔 I 〕で表わされる化合物(18)(式中
、R^1はアセチル基であり、R^2は ▲数式、化学式、表等があります▼である)の製造方法
(4) General formula [I] consisting of reacting the compound (17) represented by the general formula [I] (in the formula, R^1 is an acetyl group and R^2 is a hydroxyl group) with CCl_3CN and NaH. A method for producing a compound (18) represented by [I] (in the formula, R^1 is an acetyl group, and R^2 is ▲a mathematical formula, a chemical formula, a table, etc.).
(5)反応をCH_2Cl_2中、Ar雰囲気下で実施
する特許請求の範囲第(4)項記載の製造方法。
(5) The manufacturing method according to claim (4), wherein the reaction is carried out in CH_2Cl_2 under an Ar atmosphere.
(6)一般式〔 I 〕で表わされる化合物(18)(式
中、R^1はアセチル基であり、R^2は ▲数式、化学式、表等があります▼である)と▲数式、
化学式、表等があります▼ (式中Bzはベンゾイル基を示す)とを反応させること
からなる一般式〔 I 〕で表わされる化合物(20)(
式中、R^1はアセチル基であり、R^2は▲数式、化
学式、表等があります▼(式中Bzはベンゾイル 基で示す)である)の製造方法。 ▲数式、化学式、表等があります▼〔 I 〕
(6) Compound (18) represented by the general formula [I] (in the formula, R^1 is an acetyl group, and R^2 is ▲There are mathematical formulas, chemical formulas, tables, etc.▼) and ▲mathematical formula,
There are chemical formulas, tables, etc. ▼ Compound (20) represented by the general formula [I] consisting of reacting with (in the formula, Bz represents a benzoyl group)
In the formula, R^1 is an acetyl group, and R^2 is ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (in the formula, Bz is a benzoyl group). ▲There are mathematical formulas, chemical formulas, tables, etc.▼〔I〕
(7)反応をBF_3Et_2O及びモレキュラーシー
ブAW300の存在下実施する特許請求の範囲第(6)
項記載の製造方法。
(7) Claim No. 6 in which the reaction is carried out in the presence of BF_3Et_2O and molecular sieve AW300.
Manufacturing method described in section.
(8)一般式〔 I 〕で表わされる化合物(20)(式
中、R^1はアセチル基であり、R^2は ▲数式、化学式、表等があります▼(式中、Bzはベン
ゾイ ル基を示す)とNaOCH_3とを反応させることから
なる一般式〔 I 〕で表わさる化合物(21)(式中、
R^1は水素原子であり、R^2は▲数式、化学式、表
等があります▼である)の製造方法。 ▲数式、化学式、表等があります▼〔 I 〕
(8) Compound (20) represented by the general formula [I] (In the formula, R^1 is an acetyl group, and R^2 has a mathematical formula, chemical formula, table, etc.) (In the formula, Bz is a benzoyl group Compound (21) represented by the general formula [I], which is obtained by reacting NaOCH_3 with NaOCH_3 (in the formula,
R^1 is a hydrogen atom, and R^2 is ▲There are mathematical formulas, chemical formulas, tables, etc.▼) Manufacturing method. ▲There are mathematical formulas, chemical formulas, tables, etc.▼〔I〕
(9)一般式〔 I 〕で表わされる化合物(18)(式
中、R^1はアセチル基であり、R^2は ▲数式、化学式、表等があります▼である)と ▲数式、化学式、表等があります▼(式中、Bzはベン ゾイル基を示す)とを反応させることからなる一般式〔
I 〕で表わされる化合物(23)(式中、R^1はア
セチル基であり、R^2は ▲数式、化学式、表等があります▼(式中、Bzはベン
ゾ イル基である)である)の製造方法。 ▲数式、化学式、表等があります▼〔 I 〕
(9) Compound (18) represented by the general formula [I] (in the formula, R^1 is an acetyl group, and R^2 is ▲There are mathematical formulas, chemical formulas, tables, etc.▼) and ▲mathematical formula, chemical formula There are tables, etc. ▼ (in the formula, Bz represents a benzoyl group) and the general formula [
Compound (23) represented by [I] (in the formula, R^1 is an acetyl group, and R^2 is ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (in the formula, Bz is a benzoyl group)) manufacturing method. ▲There are mathematical formulas, chemical formulas, tables, etc.▼〔I〕
(10)反応をBF_3Et_2O及びモレキュラーシ
ーブAW300の存在下実施する特許請求の範囲第(9
)項記載の製造方法。
(10) Claim No. 9 in which the reaction is carried out in the presence of BF_3Et_2O and molecular sieve AW300.
) The manufacturing method described in section 2.
(11)一般式〔 I 〕で表わされる化合物(23)(
式中、R^1はアセチル基であり、R^2は ▲数式、化学式、表等があります▼(式中、Bzはベン
ゾ イル基を示す)である)とNaOCH_3とを反応させ
ることからなる一般式〔 I 〕で表わされる化合物(2
4)(式中、R^1は水素原子であり、R^2は▲数式
、化学式、表等があります▼であ る)の製造方法。 ▲数式、化学式、表等があります▼〔 I 〕
(11) Compound (23) represented by general formula [I] (
In the formula, R^1 is an acetyl group, and R^2 is a ▲ mathematical formula, chemical formula, table, etc. ▼ (in the formula, Bz represents a benzoyl group)) and NaOCH_3. Compound (2) represented by formula [I]
4) (In the formula, R^1 is a hydrogen atom, and R^2 is ▲ which has a mathematical formula, chemical formula, table, etc.). ▲There are mathematical formulas, chemical formulas, tables, etc.▼〔I〕
(12)一般式〔 I 〕で表わされる化合物(17)(
式中、R^1はアセチル基であり、R^2は水酸基であ
る)とDAST(ジエチルアミノサルファトリフルオラ
イド)とを反応させることからなる一般式〔 I 〕で表
わされる化合物(25)(式中、R^1はアセチル基で
あり、R^2はフッ素原子である)の製造方法。 ▲数式、化学式、表等があります▼〔 I 〕
(12) Compound (17) represented by general formula [I] (
Compound (25) represented by the general formula [I] consisting of reacting DAST (diethylaminosulfur trifluoride) with DAST (in the formula, R^1 is an acetyl group and R^2 is a hydroxyl group) (in the formula , R^1 is an acetyl group and R^2 is a fluorine atom). ▲There are mathematical formulas, chemical formulas, tables, etc.▼〔I〕
(13)一般式〔 I 〕で表わされる化合物(25)(
式中、R^1はアセチル基であり、R^2はフッ素原子
である)と▲数式、化学式、表等があります▼(式中、
Bzは ベンゾイル基である)とを反応させることからなる一般
式〔 I 〕で表わさる化合物(20)(式中、R^1は
アセチル基であり、R^2は ▲数式、化学式、表等があります▼(式中、Bzはベン
ゾイ ル基を示す)である)の製造方法。 ▲数式、化学式、表等があります▼〔 I 〕
(13) Compound (25) represented by general formula [I] (
In the formula, R^1 is an acetyl group and R^2 is a fluorine atom) and ▲ there are mathematical formulas, chemical formulas, tables, etc. ▼ (in the formula,
Compound (20) represented by the general formula [I] (wherein R^1 is an acetyl group and R^2 is a ▲ mathematical formula, chemical formula, table, etc.) There is a method for producing ▼ (in the formula, Bz represents a benzoyl group). ▲There are mathematical formulas, chemical formulas, tables, etc.▼〔I〕
(14)反応をAgClO_4、SnCl_2及びモレ
キュラーシーブ4Aの存在下で実施する特許請求の範囲
第(13)項記載の製造方法。
(14) The manufacturing method according to claim (13), wherein the reaction is carried out in the presence of AgClO_4, SnCl_2 and molecular sieve 4A.
JP17961886A 1986-07-30 1986-07-30 Globoside neutral glycolipid and production thereof Pending JPS6335591A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17961886A JPS6335591A (en) 1986-07-30 1986-07-30 Globoside neutral glycolipid and production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17961886A JPS6335591A (en) 1986-07-30 1986-07-30 Globoside neutral glycolipid and production thereof

Publications (1)

Publication Number Publication Date
JPS6335591A true JPS6335591A (en) 1988-02-16

Family

ID=16068902

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17961886A Pending JPS6335591A (en) 1986-07-30 1986-07-30 Globoside neutral glycolipid and production thereof

Country Status (1)

Country Link
JP (1) JPS6335591A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0193562A (en) * 1987-10-05 1989-04-12 Shionogi & Co Ltd Production of sphingosine derivative

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0193562A (en) * 1987-10-05 1989-04-12 Shionogi & Co Ltd Production of sphingosine derivative
JP2588729B2 (en) * 1987-10-05 1997-03-12 塩野義製薬株式会社 Sphingosine derivative

Similar Documents

Publication Publication Date Title
JPH0899989A (en) New glycolipid derivative and intermediate for its production
WO1984001777A1 (en) Method for carrying out the organic synthesis of oligosaccharides containing galactosamine-uronic acid patterns, new oligosaccharides obtained and biological applications thereof
EP0242736B1 (en) Sialosylceramides and production method thereof
CN112585124B (en) Preparation method of intermediate for synthesizing SGLT inhibitor
JPS6335591A (en) Globoside neutral glycolipid and production thereof
US5696244A (en) Method for preparing 1-N-ethylsisomicin
JPS61129197A (en) Manufacture of pregnane derivative and ester of novel androstane derivative
JPS6335588A (en) Globoside neutral glycolipid and production thereof
JP3194581B2 (en) Gibberellin separation method
JPH05178875A (en) Production of fucopyranose analog and its synthetic intermediate compound
JP2696524B2 (en) New synthesis method of ganglioside GM (3)
JPH02292295A (en) Preparation of etoposide
PL168588B1 (en) Method of disymmetrically obtaining derivatives of 3-substitute furanoside
JPS6016998A (en) Preparation of anthracycline derivative
JPS6341493A (en) Ganglioside gm2-related compound and production thereof
JPS6045588A (en) Novel oligomannoside and its preparation
JP3023804B2 (en) Method for producing 3&#39;-deoxy-3&#39;-fluorothymidine
JPS6351396A (en) Lewis type-b glycolipid and production thereof
JPS63250396A (en) 3&#39;-azido-3&#39;-deoxythymidine derivative
JPH0529237B2 (en)
JPH0273094A (en) 3-phenylthio-n-acetylneuramic acid derivative and production thereof
JPS63104986A (en) Ceramide-relating compound
JPS63156797A (en) 14-(omega,omega,omega-trifluoroalkyl)-4-demethoxydaunorubicin derivative
JPH0616667A (en) New production of pyrazolo(1,5-a)pyridine derivative
JPH04217691A (en) Synthetic intermediate for glycolipid